Scholarlink

Introduction <p>Gestational trophoblastic neoplasia (GTN) represents the malignant variant of gestational trophoblastic disease (GTD), a rare condition characterized by abnormal trophoblastic cell proliferation. GTN affects mostly women of reproductive age and is characterized by early metastatic progression. The majority of GTN tumors respond well to chemotherapy. The overall cure rate may be as high as 95 to 100 percent. Future pregnancy after treatment is an important issue. The purpose of this study was to analyze reproductive outcomes of GTN patients registered at the Center for GTD of Slovakia.</p> Methods <p>A&#xa0;retrospective analysis of pregnancy outcomes in GTN patients after treatment. The study included all recorded pregnancies in GTN patients treated with systemic therapy at the Center for GTD of Slovakia in 1993–2024.</p> Results <p>A&#xa0;total of 94 pregnancies in 51 patients were included. 44 patients (86.3%) were treated with single-agent chemotherapy and 7 (13.7%) with multi-agent chemotherapy. 41 patients (80.4%) had at least one pregnancy resulting in live birth. Of the 94 pregnancies, 61 (64.9%) resulted in live birth and 17 (18.1%) in miscarriage. Women after single-agent chemotherapy had more live births than women after multi-agent chemotherapy (68.7% vs. 36.4%, <i>p</i> = 0.035). Pregnancies conceived ≥ 12&#xa0;months after finishing treatment resulted in more live births (25 vs 2; <i>p</i> = 0.004) and less pregnancy terminations (2 vs 8; <i>p</i> &lt; 0.001) compared to those conceived earlier.</p> Conclusion <p>GTN patients can expect a&#xa0;normal course of subsequent pregnancy after treatment with comparable outcomes to the general population.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Reproductive Outcomes After Treatment of Gestational Trophoblastic Neoplasia in Slovakia

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年2月11日

查看全文
  • Liam McCullough,
  • Zuzana Niznanska,
  • Ludovit Danihel,
  • Jozef Sufliarsky,
  • Michaela Kubickova,
  • Lajos Gergely,
  • Maria Vargova,
  • Miroslav Korbel

摘要

Introduction

Gestational trophoblastic neoplasia (GTN) represents the malignant variant of gestational trophoblastic disease (GTD), a rare condition characterized by abnormal trophoblastic cell proliferation. GTN affects mostly women of reproductive age and is characterized by early metastatic progression. The majority of GTN tumors respond well to chemotherapy. The overall cure rate may be as high as 95 to 100 percent. Future pregnancy after treatment is an important issue. The purpose of this study was to analyze reproductive outcomes of GTN patients registered at the Center for GTD of Slovakia.

Methods

A retrospective analysis of pregnancy outcomes in GTN patients after treatment. The study included all recorded pregnancies in GTN patients treated with systemic therapy at the Center for GTD of Slovakia in 1993–2024.

Results

A total of 94 pregnancies in 51 patients were included. 44 patients (86.3%) were treated with single-agent chemotherapy and 7 (13.7%) with multi-agent chemotherapy. 41 patients (80.4%) had at least one pregnancy resulting in live birth. Of the 94 pregnancies, 61 (64.9%) resulted in live birth and 17 (18.1%) in miscarriage. Women after single-agent chemotherapy had more live births than women after multi-agent chemotherapy (68.7% vs. 36.4%, p = 0.035). Pregnancies conceived ≥ 12 months after finishing treatment resulted in more live births (25 vs 2; p = 0.004) and less pregnancy terminations (2 vs 8; p < 0.001) compared to those conceived earlier.

Conclusion

GTN patients can expect a normal course of subsequent pregnancy after treatment with comparable outcomes to the general population.